Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer

Condition:   Triple Negative Breast Cancer Interventions:   Drug: Gemcitabine and carboplatin plus antibiotic (moxifloxacin);   Drug: Gemcitabine combined with carboplatin plus placebo Sponsor:   Sun Yat-sen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials